AbCellera Biologics Inc. Common Shares ABCL

$10.97 +5.94% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-08-14 View →
4 FORM 4 2026-08-14 View →
8-K 8-K 2026-08-13 View →
424B5 424B5 2026-08-13 View →
4 FORM 4 2026-08-13 View →
424B5 424B5 2026-08-11 View →
8-K 8-K 2026-08-10 View →
8-K 8-K 2026-08-07 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
8-K 8-K 2026-07-29 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
8-K 8-K 2026-07-06 View →
8-K 8-K 2026-06-17 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
4 FORM 4 2026-06-12 View →
8-K 8-K 2026-06-12 View →
8-K 8-K 2026-06-05 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-05-18 View →
10-Q 10-Q 2026-05-11 View →
8-K 8-K 2026-05-11 View →
DEF 14A DEF 14A 2026-04-29 View →
4 FORM 4 2026-03-02 View →
4 FORM 4 2026-02-27 View →
4 FORM 4 2026-02-27 View →
10-K 10-K 2026-02-24 View →
8-K 8-K 2026-02-24 View →
8-K 8-K 2026-01-14 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2025-12-19 View →
4 FORM 4 2025-12-19 View →
8-K 8-K 2025-12-18 View →
8-K 8-K 2025-11-28 View →
4 FORM 4 2025-11-26 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$10.97
Market Cap
$3.17 billion
52-Week Range
$2.75 $11.06
Average Volume
8.16 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.